Found 54 matching trials
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
PHASE2To assess the efficacy and safety of Human coronavirus immune plasma (HCIP)...
Location
University of Alabama at Birmingham
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)
PHASE1This pilot, prospective study will assess the safety and efficacy of COVID-...
Location
Houston Methodist Hopsital
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
PHASE2The aim of this project is to introduce way for treatment of patients with ...
Location
Ain Shams University
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients
PHASE1Due to the limitations of COVID-19 treatment and in the absence of licensed...
Location
Ministry Of Health
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
PHASE3In this study, investigators will determine whether the early addition of H...
Location
Brigham and Women's Hospital
Convalescent Plasma for COVID-19 Research Donor Study
N/AConvalescent Plasma for COVID-19 Research (CONCOR-Donor) study, is a nation...
Location
The Hospital for Sick Children
Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients
PHASE2A total of 278 patients are planned.
All patients will be in an early-stag...
Location
Hospital Clínico Universitario Lozano Blesa
Efficacy and Safety of COVID-19 Convalescent Plasma
NAAdministration of convalescent plasma obtained from donors with prior docum...
Location
Institute for Transfusion Medicine of RNM
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan
NABeyond supportive care, there are currently no proven treatment options for...
Location
Pak Emirates Military Hospital
Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19
PHASE3* Research Question: Does convalescent plasma (CCP) collected from donors w...